Abstract
The discovery of a receptor for renin and for its inactive precursor prorenin, and the introduction of renin inhibitors in therapeutic, has renewed the interest for the physiology of the renin angiotensin system (RAS) and has brought prorenin back in the spotlight. The receptor known as renin for (Pro)Renin Receptor binds both renin and prorenin, and binding triggers intracellular signaling involving the MAP kinases ERK1/2 and p38. The MAP kinases activation in turn upregulates the expression of profibrotic genes, potentially leading to fibrosis, growth, and remodeling. Simultaneously, binding of renin to (P)RR increases its angiotensin I-generating activity, whereas binding of prorenin induces the inactive prorenin to become enzymatically active. These biochemical characteristics of (pro)renin binding to (P)RR allow to distinguish two aspects for the new (pro)renin/(P)RR system, an angiotensin-independent function related to the intracellular signaling and its downstream effects and an angiotensin-dependent aspect related to the increased generation of angiotensin I on the cell surface. Ongoing experimental studies should now determine which of the two aspects is the most important in pathological situations.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- (pro)renin::
-
designate renin and prorenin
- AOG::
-
angiotensinogen
- Ang I and Ang II::
-
angiotensin I and angiotensin II
- ACE::
-
angiotensin-converting enzyme
- HRP::
-
handle region peptide
- (P)RRB::
-
(pro)renin receptor blocker
References
Danser, A.H.J., Derkx, F.H.M., Schalekamp, M.A.D.H., et al. (1998). Determinants of interindividual variation of renin and prorenin concentrations: evidence for a sexual dimorphism of (pro)renin levels in humans. J Hypertens 16, 853–862.
Krop, M., and Danser, A.H.J. (2008). Circulating versus tissue renin-angiotensin system: on the origin of (pro)renin. Curr Hyp Rep 10, 112–118.
Danser, A.H.J., and Deinum, J. (2005). Renin, prorenin and the putative (pro)renin receptor. Hypertension 46, 1069–1076.
Luetscher, J.A., Kraemer, F.B., Wilson, D.M., et al. (1985). Increased plasma inactive renin in diabetes mellitus. A marker of microvascular complications. N Engl J Med 312, 1412–1417.
Wilson, D.M., and Luetscher, J.A. (1990) Plasma prorenin activity and complications in children with insulin-dependent diabetes mellitus. N Engl J Med 323, 1101–1106.
Stankovic, A.R., Fisher, N.D.L., and Hollenberg, N.K. (2006). Prorenin and angiotensin-dependent renal vasoconstriction in type 1 and type 2 diabetes. J Am Soc Nephrol 17, 3293–3299.
Lenz, T., Sealey, J.E., Maack, T., et al. (1991). Half-life, hemodynamic, renal, and hormonal effects of prorenin in cynomolgus monkeys. Am J Physiol 260, R804–R810.
Véniant, M., Ménard, J., Bruneval, P., et al. (1996). Vascular damage without hypertension in transgenic rats expressing prorenin exclusively in the liver. J Clin Invest 98, 1966–1970.
Prescott, G., Silversides, D.W., and Reudelhuber, T.L. (2002). Tissue activity of circulating prorenin. Am J Hypertens 15, 280–285.
Peters, B., Grisk, O., Becher, B., et al. (2008). Dose-dependent titration of prorenin and blood pressure in Cyp1a1ren-2 transgenic rats: absence of prorenin-induced glomerulosclerosis. J Hypertens 26, 102–109.
Methot, D., Silversides, D.W., and Reudelhuber, T.L. (1999). In vivo enzymatic assay reveals catalytic activity of the human renin precursor in tissues. Circ Res 84, 1067–1072.
Maru, I., Ohta, Y., Murata, K., et al. (1996). Molecular cloning and identification of N-acyl-D-glucosamine 2-epimerase from porcine kidney as a renin-binding protein. J Biol Chem 271, 16294–16299.
van Kesteren, C.A.M., Danser, A.H.J., Derkx, F.H.M., et al. (1997). Mannose 6-phosphate receptor-mediated internalization and activation of prorenin by cardiac cells. Hypertension 30, 1389–1396.
Saris, J.J., Derkx, F.H.M., de Bruin, R.J.A., et al. (2001a). High-affinity prorenin binding to cardiac man-6-P/IGF-II receptors precedes proteolytic activation to renin. Am J Physiol 280, H1706–H1715.
van den Eijnden, M.M.E.D., Saris, J.J., et al. (2001). Prorenin accumulation and activation in human endothelial cells. Importance of mannose 6-phosphate receptors. Arterioscler Thromb Vasc Biol 21, 911–916.
Schmitz, C., Gotthardt, M., Hinderlich, S., et al. (2000). Normal blood pressure and plasma renin activity in mice lacking the renin-binding protein, a cellular renin inhibitor. J Biol Chem 275, 15357–15362.
Saris, J.J., van den Eijnden, M.M.E.D., Lamers, J.M.J., et al. (2002). Prorenin-induced myocyte proliferation: no role for intracellular angiotensin II. Hypertension 39, 573–577.
Nguyen, G., Delarue, F., et al. (2002). Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest 109, 1417–1427.
Huang, Y., Wongamorntham, S., Kasting, J., et al. (2006). Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms. Kidney Int 69, 105–113.
Huang, Y., Noble, N.A., Zhang, J., Xu, C., et al. (2007b). Renin-stimulated TGF-beta1 expression is regulated by a mitogen-activated protein kinase in mesangial cells. Kidney Int 72, 45–52.
Sakoda, M., Ichihara, A., Kaneshiro, Y., et al. (2007). (Pro)renin receptor-mediated activation of mitogen-activated protein kinases in human vascular smooth muscle cells. Hypertens Res 30, 1139–1146.
Feldt, S., Batenburg, W.W., Mazak, I., et al. (2008a). Prorenin and renin-induced extracellular signal-regulated kinase 1/2 activation in monocytes is not blocked by aliskiren or the handle-region peptide. Hypertension 51, 682–688.
Huang, Y., Border, W.A., and Noble, N.A. (2007a). Functional renin receptors in renal mesangial cells. Curr Hypertens Rep 9, 133–139.
Saris, J.J., ’t Hoen, P.A.C., Garrelds, I.M., et al. (2006). Prorenin induces intracellular signalling in cardiomyocytes independently of angiotensin II. Hypertension 48, 564–571.
Schefe, J.H., Menk, M., Reinemund, J., et al. (2006). A novel signal transduction cascade involving direct physical interaction of the renin/prorenin receptor with the transcription factor promyelocytic zinc finger protein. Circ Res 99, 1355–1366.
Schefe, J.H., Neumann, C., Goebel, M., et al. (2008) Prorenin engages the (pro)renin receptor like renin and both ligand activities are unopposed by aliskiren. J Hypertens 26, 1787–1794.
Batenburg, W.W., Krop, M., and Garrelds, I.M., et al. (2007). Prorenin is the endogenous agonist of the (pro)renin receptor. Binding kinetics of renin and prorenin in rat vascular smooth muscle cells overexpressing the human (pro)renin receptor. J Hypertens 25, 2441–2453.
Nabi, A.H., Kageshina, A., Uddin, M.N., Nakagawa, T. ,et al. (2006) Binding properties of rat prorein and renin to recombinant rat renin prorein receptor prepared by a baculovir expression system. Int. I Mol Med 18, 483–488
Suzuki, F., Hayakawa, M., Nakagawa, T., et al. (2003). Human prorenin has “gate and handle” regions for its non-proteolytic activation. J Biol Chem 278, 22217–22222.
Ichihara, A., Hayashi, M., Kaneshiro, Y., et al. (2004). Inhibition of diabetic nephropathy by a decoy peptide corresponding to the “handle” region for nonproteolytic activation of prorenin. J Clin Invest 114, 1128–1135.
Ichihara, A., Kaneshiro, Y., Takemitsu, T., et al. (2006a). Nonproteolytic activation of prorenin contributes to development of cardiac fibrosis in genetic hypertension. Hypertension 47, 894–900.
Satofuka S, Ichihara A, Nagai N, et al. (2006). Suppression of ocular inflammation in endotoxin-induced uveitis by inhibiting nonproteolytic activation of prorenin. Invest Ophthalmol Vis Sci 47, 2686–2692.
Müller, D.N., Klanke, B., Feldt, S., et al. (2008). (Pro)renin receptor peptide inhibitor “handle-region” peptide does not affect hypertensive nephrosclerosis in Goldblatt rats. Hypertension 51, 676–681.
Burcklé, C.A., Danser, A.H.J., Müller, D.N., et al. (2006). Elevated blood pressure and heart rate in human renin receptor transgenic rats. Hypertension 47, 552–556.
Kaneshiro, Y., Ichihara, A., Sakoda, M., et al. (2007). Slowly progressive, angiotensin II-independent glomerulosclerosis in human (pro)renin receptor-transgenic rats. J Am Soc Nephrol 18, 1789–1795.
Kaneshiro, Y., Ichihara, A., Takemitsu, T., et al. (2006). Increased expression of cyclooxygenase-2 in the renal cortex of human prorenin receptor gene-transgenic rats. Kidney Int 70, 641–646.
Krebs, C., Hamming, I., and Sadaghiani, S., et al. (2007). Antihypertensive therapy upregulates renin and (pro)renin receptor in the clipped kidney of Goldblatt hypertensive rats. Kidney Int 72, 725–730
Siragy, H.M., and Huang, J. (2008) Renal (pro)renin receptor upregulation in diabetic rats through enhanced angiotensin AT1 receptor and NADPH oxidase activity. Exp Physiol 93(5), 709–714
Ichihara, A., Suzuki, F., and Nakagawa, T., et al. (2006b). Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor-deficient mice. J Am Soc Nephrol 17, 1950–1961.
Burcklé, C., and Bader, M. (2006). Prorenin and its ancient receptor. Hypertension 48, 549–551.
Ludwig, J., Kerscher, S., Brandt, U., et al. (1998). Identification and characterization of a novel 9.2-kDa membrane sector-associated protein of vacuolar proton-ATPase from chromaffin granules. J Biol Chem 273, 10939–10947.
Nishi, T., and Forgac, M. (2002). The vacuolar (H+)-ATPases–nature’s most versatile proton pumps. Nat Rev Mol Cell Biol 3, 94–103.
Amsterdam, A., Nissen, R.M., Sun, Z., et al. (2004). Identification of 315 genes essential for early zebrafish development. Proc Natl Acad Sci USA 101, 12792–12797.
Contrepas, A., Praizovic, N., Duong Van Huyen, J.P., et al. (2007). Expression of (pro)renin receptor in mouse embryonic and newborn kidney and proliferative effect of soluble (P)RR on mesangial cells. Hypertension 50, e145 (Abstract).
L’Huillier, N., Sharp, M.G.F., Dunbar, D.R., et al. (2006). On the relationship between the renin receptor and the vacuolar proton ATPase membrane sector associated protein (M8-9). In: E.D. Frolich and R.N. Re. (eds.) The Local Cardiac Renin Angiotensin-Aldosterone System. Chapter 3. Springer, 233 spring street, new york NY10013, USA, pp. 17–34.
Tigerstedt, R., and Bergman, P.G. (1898). Niere und Kreislauf. Scand Arch Physiol 8, 223–271.
Nguyen, G., and Danser, A.H. (2008) Prorenin and (pro)renin receptor: a review of available data from in vitro studies and experimental models in rodents. Exp Physiol 93, 557–563.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Nguyen, G., Contrepas, A. (2009). Renin, Prorenin, and the (Pro)Renin Receptor. In: DeMello, W., Frohlich, E. (eds) Renin Angiotensin System and Cardiovascular Disease. Contemporary Cardiology. Humana Press. https://doi.org/10.1007/978-1-60761-186-8_3
Download citation
DOI: https://doi.org/10.1007/978-1-60761-186-8_3
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60761-185-1
Online ISBN: 978-1-60761-186-8
eBook Packages: MedicineMedicine (R0)